SCHEMBL3041847

SCHEMBL3041847

O=C(Cc1cccs1)Oc1ccc2ccccc2c1CO

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ POLB P06746 2/20 0.49
▸ BLM P54132 1/20 0.49
▸ PDGFRB P09619 1/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ NCEH1 Q6PIU2 3/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CASP3 P42574 1/20 0.38
▸ CASP7 P55210 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3041845 0.81 HPGD (0.53) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL4619856 0.70 NPC1 (0.56) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL3054334 0.70 MEN1 (0.65) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL2550650 0.69 NPC1 (0.54) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL11217076 0.68 NPC1 (0.55) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL7904268 0.68 NPC1 (0.44) ALDH1A1KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL29620186 0.67 MAPT (0.58) KMT2AMEN1HPGDSMN1; SMN2POLB
SCHEMBL702988 0.67 MAPT (0.58) KMT2AMEN1HPGDSMN1; SMN2POLB
SCHEMBL3041200 0.67 NCEH1 (0.41) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL6753122 0.67 CYP2C9 (0.50) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8647878-B2 Highly refractive immersion liquids and their use CARL ZEISS AG (DE) 2014-02-11 — — US disclosed
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use CARL ZEISS AG (DE) 2010-08-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100212547-A1 Highly Refractive Immersion Liquids And Their Use NR4A3, NR2E3, NR4A1 ALDH1A1 3757/4885KMT2A 3367/4885MEN1 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback